Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review.
AI tools can accurately identify fatty liver disease, though consistent testing standards are needed before widespread clinical use.
This systematic review evaluates AI tools for diagnosing metabolic dysfunction-associated steatotic liver disease (formerly NAFLD). While multiple AI approaches show good accuracy, the field needs standardized benchmarks and external validation.
What the study was
- Study design
- Systematic review
- Population
- Patients with metabolic dysfunction-associated steatotic liver disease
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Computers in biology and medicine
Why it surfaced
Systematic review of AI in liver disease diagnostics. Review design limits novelty; high clinical relevance for MASLD.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.